bullish

AFT Pharmaceuticals (AFT): Solid 2Q27 Update

88 Views06 Oct 2026 04:44
Broker
AFT indicated it remains on track to reach NZ$300m in revenue in FY27, in line with our NZ$303m estimate Reiterated operating profit (EBIT) of...
What is covered in the Full Insight:
  • Introduction
  • FY27 Revenue and Profit Guidance
  • 1H27 Revenue Growth by Division
  • Inventory Management Strategy
  • Growth Volatility in Key Regions
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • AFT Pharmaceuticals (AFT): Solid 2Q27 Update
    06 Oct 2026
x